Inventor · disambiguated record
Markus Haake
Also filed as: HAAKE MARKUS
14 granted patents·2 pending applications·7 citations·filing 2012–2025
88Inventor score
Files withARIDIS PHARMACEUTICALS INC9UNIV WUERZBURG J MAXIMILIANS4CATALYM GMBH2ARIDIS PHARMACEUTICALS1
Top patents by PatentIndex Score
16 records- 0187US11262360B2GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockersUNIV WUERZBURG J MAXIMILIANS·Filed 2016·Granted Mar 1, 2022·4 cites·10 claims
- 0283US11464856B2Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockersUNIV WUERZBURG J MAXIMILIANS·Filed 2016·Granted Oct 11, 2022·3 cites·18 claims
- 0379US10682404B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2019·Granted Jun 16, 2020·0 cites·10 claims
- 0474US10603373B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Mar 31, 2020·0 cites·2 claims
- 0572US12473354B2GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockersUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Granted Nov 18, 2025·0 cites·11 claims
- 0672US10603372B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Mar 31, 2020·0 cites·6 claims
- 0769US12497447B2Anti-GDF15 antibody and a dosage regimen for the treatment of cancerCATALYM GMBH·Filed 2025·Granted Dec 16, 2025·0 cites·17 claims
- 0868US10420828B2Targets of acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Sep 24, 2019·0 cites·6 claims
- 0968US10398767B2Targets of Acinetobacter BaumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Sep 3, 2019·0 cites·5 claims
- 1068US10111942B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Oct 30, 2018·0 cites·6 claims
- 1168US10098942B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Oct 16, 2018·0 cites·6 claims
- 1268US2023093412A1Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockersUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Application pending·0 cites
- 1367US10463727B2Targets of acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·0 cites·7 claims
- 1465US10105432B2Targets of acinetobacter baumanniiARIDIS PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·0 cites·7 claims
- 1563US2024043517A1Anti-gdf15 antibody and a dosage regimen for the treatment of cancerCATALYM GMBH·Filed 2023·Application pending·0 cites
- 1652US9597387B2Targets of Acinetobacter baumanniiARIDIS PHARMACEUTICALS·Filed 2012·Granted Mar 21, 2017·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Markus Haake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →